OPKO Health’s (OPK) Board of Directors has authorized an increase of $100M to the Company’s existing common stock repurchase program, bringing the aggregate capacity of the program to $200M. Approximately $41M of OPKO’s common stock has been repurchased under the existing program since its authorization in July 2024.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPK:
- Opko Health management to meet with Piper Sandler
- Best Buy, Las Vegas Sands, Globalstar, Opko Health, Agilent: Stock Moves Unveiled
- Strategic Partnerships and Asset Sales Bolster OPKO Health’s Growth Prospects
- Opko Health CEO buys $348K in common stock
- Opko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptide
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue